Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6995 USD | -6.30% | -15.16% | +79.36% |
Apr. 18 | Renalytix chief business officer to become president | AN |
Apr. 18 | Renalytix Names Chief Business Officer as President | MT |
Financials (USD)
Sales 2024 * | 4M | Sales 2025 * | 18M | Capitalization | 43.64M |
---|---|---|---|---|---|
Net income 2024 * | -35M | Net income 2025 * | -26M | EV / Sales 2024 * | 10.9 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.42 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.43% |
Latest transcript on Renalytix Plc
1 day | -6.30% | ||
1 week | -15.16% | ||
Current month | -18.66% | ||
1 month | -22.84% | ||
3 months | +141.21% | ||
6 months | -36.41% | ||
Current year | +79.36% |
Managers | Title | Age | Since |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 18-03-14 |
James Sterling
DFI | Director of Finance/CFO | 54 | 18-03-14 |
Thomas McLain
PSD | President | 66 | 19-07-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 74 | 21-08-29 |
Chairman | 72 | 18-03-14 | |
James McCullough
FOU | Founder | 56 | 18-03-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 0.7465 | -6.92% | 204,760 |
24-04-19 | 0.802 | +2.17% | 30,126 |
24-04-18 | 0.785 | -5.42% | 209,438 |
24-04-17 | 0.83 | +0.67% | 123,750 |
24-04-16 | 0.8245 | -2.15% | 83,529 |
Delayed Quote Nasdaq, April 23, 2024 at 04:30 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.18% | 2.61B | |
+15.62% | 1.76B | |
-2.14% | 1.51B | |
+21.84% | 1.17B | |
-13.27% | 943M | |
-21.67% | 883M | |
-6.04% | 701M | |
-15.76% | 693M | |
+12.74% | 509M |
- Stock Market
- Equities
- RENX Stock
- RNLX Stock